LAMBERTINI M

Temporary ovarian suppression with gonadotropin‐releasing hormone agonist during chemotherapy might be a reliable strategy not only to preserve ovarian function but also to increase the likelihood of becoming pregnant after the end of cytotoxic therapy. The findings of Blumenfeld et al. are consistent with recent data suggesting the efficacy of...

Introduction: Breast cancer in young women represents a public health problem with specific age-related issues to be faced by both patients and their treating physicians.Areas covered: This manuscript reviews the recent data on the medical management of young women with early-stage HER2-negative breast cancer.Expert opinion: For women...